Compare · ESP vs TMO
ESP vs TMO
Side-by-side comparison of Espey Mfg. & Electronics Corp. (ESP) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- ESP operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $222.97B, about 1179.6x ESP ($189.0M).
- TMO has been more active in the news (13 items in the past 4 weeks vs 2 for ESP).
- TMO has more recent analyst coverage (25 ratings vs 0 for ESP).
- Company
- Espey Mfg. & Electronics Corp.
- Thermo Fisher Scientific Inc
- Price
- -
- -
- Market cap
- $189.0M
- $222.97B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 1960
- News (4w)
- 2
- 13
- Recent ratings
- 0
- 25
Espey Mfg. & Electronics Corp.
Espey Mfg. & Electronics Corp., a power electronics design and original equipment manufacturing company, designs, manufactures, and tests electronic equipment primarily for use in military and industrial applications in the United States and internationally. Its principal products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, antennas, and high power radar systems for use in AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power applications. The company also provides various services that consist of design and development to specification, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment. It serves industrial manufacturers and defense companies, the government of the United States, foreign governments, and foreign electronic equipment companies through its direct sales organization and outside sales representatives. Espey Mfg. & Electronics Corp. was founded in 1928 and is based in Saratoga Springs, New York.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ESP
- Espey Mfg. & Electronics Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Espey Announces Special Cash Dividend of $0.75 Per Share Plus Regular Quarterly Dividend of $0.25 Per Share, and the promotion of Kaitlyn O’Neil to Chief Financial Officer
- Director Wool Michael W gifted 2,000 units of Common Stock - $.33 1/3 par value, decreasing direct ownership by 10% to 17,792 units (SEC Form 4)
- Director Wool Michael W gifted 100 units of Common Stock - $.33 1/3 par value, decreasing direct ownership by 0.50% to 19,792 units (SEC Form 4)
- Director Helmetag Carl sold $63,662 worth of Common Stock - $.33 1/3 par value (1,000 units at $63.66), decreasing direct ownership by 4% to 23,169 units (SEC Form 4)
- Director Corr Paul J exercised 2,550 units of Common Stock - $.33 1/3 par value at a strike of $18.05 and sold $168,023 worth of Common Stock - $.33 1/3 par value (2,550 units at $65.89) (SEC Form 4)
- Director Wool Michael W gifted 1,500 units of Common Stock - $.33 1/3 par value, decreasing direct ownership by 7% to 19,892 units (SEC Form 4)
- CHRO & Corporate Secretary Pickering Jennifer Michele exercised 2,500 units of Common Stock - $.33 1/3 par value at a strike of $24.46 and sold $157,500 worth of Common Stock - $.33 1/3 par value (2,500 units at $63.00) (SEC Form 4)
- President & CEO Oneil David A sold $169,275 worth of Common Stock - $.33 1/3 par value (2,500 units at $67.71), decreasing direct ownership by 15% to 13,750 units (SEC Form 4)
- Espey Declares Regular Quarterly Dividend of $0.25 Per Share
Latest TMO
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
- SVP and General Counsel Shropshire Thomas B Jr. covered exercise/tax liability with 49 shares, decreasing direct ownership by 0.81% to 6,008 units (SEC Form 4)
- Sr. VP and Chief HR Officer Britt Lisa P. covered exercise/tax liability with 394 shares, decreasing direct ownership by 3% to 14,391 units (SEC Form 4)
- Sr. Vice President & CFO Meyer James covered exercise/tax liability with 270 shares, decreasing direct ownership by 5% to 5,560 units (SEC Form 4)
- Chairman & CEO Casper Marc N covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 1% to 122,669 units (SEC Form 4)
- VP & Chief Accounting Officer Holmes Joseph R. covered exercise/tax liability with 50 shares, decreasing direct ownership by 2% to 2,916 units (SEC Form 4)
- President & COO Pettiti Gianluca covered exercise/tax liability with 1,035 shares, sold $2,539,233 worth of shares (4,133 units at $614.38) as part of a pre-agreed trading plan and exercised 3,733 shares at a strike of $309.63, decreasing direct ownership by 6% to 23,216 units (SEC Form 4)
- Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026
- Chairman & CEO Casper Marc N exercised 275 shares at a strike of $309.63 and sold $172,439 worth of shares (275 units at $627.05) as part of a pre-agreed trading plan (SEC Form 4)